Supernus Pharmaceuticals, Inc.

Rockville, MD ManufacturingNAICS 325410

Self-funded health planPlan year 2025Renews January
773Participants+10% vs. prior year
$1.8MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#12 of 19Manufacturing in MDBy participants

Overview

Supernus Pharmaceuticals, Inc. sponsors a self-funded health plan that covered 773 participants in plan year 2025, up 10% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
773 · prior year 700
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Supernus Pharmaceuticals Employee Welfare Benefits Plan, plan 510 (773 participants)
Broker compensation
$300K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilityDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Life Insurance Company of North AmericaLife, Short-term disability, Long-term disability773$938K$152K
UnitedHealthcare Insurance CompanyDental, Vision2,117$937K$141K
Trustmark Insurance CompanyLife39$47K$4K
MetLife Legal PlansLegal115$29K$3K
Curalinc LLCEmployee Assistance Program672$13K—

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$1.8M/ year

Estimated prescription spend: 773 participants × $2,371 national average per member. Usually higher once dependents are counted.

$48K–$117K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$14K–$35K
Lower-cost therapeutic alternatives$20K–$43K
Generic pricing vs. actual cost$9K–$26K
PBM contract terms$5K–$14K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Supernus Pharmaceuticals, Inc.
Sponsor EIN
20-2590184
Plan number
510
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 20-2590184 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Supernus Pharmaceuticals, Inc. 401(k) Profit Sharing Plan
Type
401(k) plan
Participants
1,074

About this data

Source: Supernus Pharmaceuticals, Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Supernus Pharmaceuticals, Inc..

Request a correction · Methodology